Related Experiment Video
Updated: Jan 27, 2026

Preparation of Highly Porous Coordination Polymer Coatings on Macroporous Polymer Monoliths for Enhanced Enrichment of Phosphopeptides
Published on: July 14, 2015
Nanoscale Coordination Polymers for Synergistic NO and Chemodynamic Therapy of Liver Cancer
1State Key Laboratory of Natural Medicines, Department of Pharmaceutical Analysis and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases , China Pharmaceutical University , Nanjing 210009 , China.
Abstract:
Nitric oxide (NO) induces a multitude of antitumor activities, encompassing the induction of apoptosis, sensitization to chemo-, radio-, or immune-therapy, and inhibition of metastasis, drug resistance, angiogenesis, and hypoxia, thus attracting much attention in the area of cancer intervention. To improve the precise targeting and treatment efficacy of NO, a glutathione (GSH)-sensitive NO donor (1,5-bis[(l-proline-1-yl)diazen-1-ium-1,2-diol- O2-yl]-2,4-dinitrobenzene, BPDB) coordinates with iron ions to form the nanoscale coordination polymer (NCP) via a simple precipitation and then partial ion exchange process. The obtained Fe(II)-BNCP shows desirable solubility, biocompatibility, and circulation stability. Quick NO release triggered by high concentrations of GSH in tumor cells improves the specificity of NO release in situ, thus avoiding side effects in other tissues. Meanwhile, under high concentrations of H2O2 in tumors, Fe2+ ions in BPDB-based NCP, named Fe(II)-BNCP, exert Fenton activity to generate hydroxyl radicals (·OH), which is the main contribution for chemodynamic therapy (CDT). In addition, ·O2- generated by the Haber-Weiss reaction of Fe2+ ions with H2O2 can quickly react with NO to produce peroxynitrite anion (ONOO-) that is more cytotoxic than ·O2- or NO only. This synergistic NO-CDT effect has been proved to retard the tumor growth in Heps xenograft ICR mouse models. This work not only implements a synergistic effect of NO-CDT therapy but also offers a simple and efficient strategy to construct a coordination polymer nanomedicine via rationally designed prodrug molecules such as NO donors.
Insights
This study developed a novel nanoscale coordination polymer (NCP) for cancer therapy. The NCP releases nitric oxide (NO) and generates hydroxyl radicals (·OH) for synergistic NO-chemodynamic therapy (CDT), effectively inhibiting tumor growth.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Nitric oxide (NO) exhibits significant antitumor properties, including apoptosis induction and therapy sensitization.
- Developing targeted NO delivery systems is crucial for enhancing cancer treatment efficacy and minimizing side effects.
- Existing strategies often lack specificity, leading to off-target effects.
Purpose of the Study:
- To design and synthesize a glutathione (GSH)-sensitive nanoscale coordination polymer (NCP) for targeted nitric oxide (NO) delivery.
- To investigate the synergistic anticancer effects of NO combined with chemodynamic therapy (CDT) mediated by the NCP.
- To evaluate the therapeutic efficacy of the novel nanomedicine in a preclinical tumor model.
Main Methods:
- Synthesis of a nanoscale coordination polymer (NCP) using a GSH-sensitive NO donor (BPDB) and iron ions.
- Characterization of the Fe(II)-BNCP for solubility, biocompatibility, and stability.
- In vitro evaluation of NO release triggered by GSH and ·OH generation via Fenton activity in the presence of H2O2.
- In vivo assessment of tumor growth inhibition in Heps xenograft ICR mouse models using the synergistic NO-CDT approach.
Main Results:
- The synthesized Fe(II)-BNCP demonstrated good solubility, biocompatibility, and circulation stability.
- High GSH concentrations in tumor cells triggered specific NO release from the NCP.
- Fe(II)-BNCP effectively generated hydroxyl radicals (·OH) via Fenton reactions, contributing to CDT.
- The combination of NO release and ·OH generation resulted in a synergistic cytotoxic effect, significantly retarding tumor growth in vivo.
Conclusions:
- The developed Fe(II)-BNCP nanomedicine offers a promising strategy for synergistic nitric oxide-chemodynamic therapy (NO-CDT).
- The GSH-sensitive design ensures targeted NO release within tumor microenvironments, enhancing specificity.
- This work presents an efficient method for constructing coordination polymer nanomedicines using rationally designed prodrugs.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Coordination Number and Geometry
Targeted Cancer Therapies
There are several types of targeted therapies against...
Polymers
Coordination Compounds and Nomenclature
Lattice Centering and Coordination Number
Types of Unit Cells
Imagine taking a large number of identical...

